Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 254, doi. 10.23736/S2724-5985.21.02875-8
- By:
- Publication type:
- Article
Works matching IS 27245985 AND DT 2021 AND VI 67 AND IP 3
Results: 12
1
2
Impact of direct antiviral agents (DAAs) on B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 227, doi. 10.23736/S2724-5985.21.02834-8
- By:
- Publication type:
- Article
3
Liver stiffness: a motivational tool for achieving alcohol abstention in alcohol use disorder patients?
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 299, doi. 10.23736/S2724-5985.21.02837-3
- By:
- Publication type:
- Article
4
The efficacy of fasting regimens on health outcomes: a systematic overview.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 289, doi. 10.23736/S2724-5985.20.02757-9
- By:
- Publication type:
- Article
5
Intestinal perforations after endoscopic retrograde cholangiopancreatography in the USA: a 16-year study using the National Inpatient Sample.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 276, doi. 10.23736/S2724-5985.20.02718-X
- By:
- Publication type:
- Article
6
Acute-on-chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patient.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 283, doi. 10.23736/S2724-5985.21.02893-X
- By:
- Publication type:
- Article
7
Endoscopic retrograde cholangiopancreatography related perforations: is there plenty to discover?
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 273, doi. 10.23736/S2724-5985.20.02736-1
- By:
- Publication type:
- Article
8
The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 264, doi. 10.23736/S2724-5985.21.02835-X
- By:
- Publication type:
- Article
9
Impact of antiviral therapy with direct acting antiviral agents (DAAs) on kidney disease in patients with chronic hepatitis C.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 244, doi. 10.23736/S2724-5985.21.02849-X
- By:
- Publication type:
- Article
10
Impact of direct acting antivirals (DAA) on neurologic disorders in chronic hepatitis C.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 234, doi. 10.23736/S2724-5985.21.02865-5
- By:
- Publication type:
- Article
11
Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 218, doi. 10.23736/S2724-5985.21.02848-8
- By:
- Publication type:
- Article
12
Long-term benefits of viral clearance on extrahepatic manifestations of hepatitis C virus infection: the light at the end of the tunnel?
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 215, doi. 10.23736/S2724-5985.21.02924-7
- By:
- Publication type:
- Article